X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (15) 15
humans (11) 11
gastroenterology & hepatology (9) 9
female (8) 8
male (8) 8
aged (7) 7
cancer (7) 7
middle aged (7) 7
surgery (7) 7
hilar cholangiocarcinoma (6) 6
mortality (6) 6
perihilar cholangiocarcinoma (5) 5
prognosis (5) 5
retrospective studies (5) 5
sarcopenia (5) 5
carcinoma (4) 4
computed tomography (4) 4
diagnosis (4) 4
kaplan-meier estimate (4) 4
liver (4) 4
liver cancer (4) 4
liver diseases (4) 4
management (4) 4
survival (4) 4
treatment outcome (4) 4
tumors (4) 4
adenoma (3) 3
adult (3) 3
article (3) 3
bile duct neoplasms - pathology (3) 3
biliary drainage (3) 3
cardiac & cardiovascular systems (3) 3
cholangiocarcinoma (3) 3
classification (3) 3
follow-up (3) 3
gastroenterology and hepatology (3) 3
liver neoplasms - pathology (3) 3
models (3) 3
netherlands (3) 3
patients (3) 3
percutaneous coronary intervention (3) 3
risk factors (3) 3
staging system (3) 3
abridged index medicus (2) 2
analysis (2) 2
angioplasty, balloon, coronary - instrumentation (2) 2
bare-metal stent (2) 2
benign (2) 2
bile duct neoplasms - mortality (2) 2
bile duct neoplasms - therapy (2) 2
body mass index (2) 2
carcinoma, hepatocellular - drug therapy (2) 2
carcinoma, hepatocellular - pathology (2) 2
cardiology (2) 2
chi-square distribution (2) 2
cirrhosis (2) 2
clinical medicine (2) 2
computed-tomography (2) 2
drug-eluting stents (2) 2
follow-up studies (2) 2
hepatocellular adenoma (2) 2
hepatocellular carcinoma (2) 2
implantation (2) 2
incidence (2) 2
klatskin (2) 2
klatskin tumor - mortality (2) 2
klatskin tumor - pathology (2) 2
klatskin tumor - therapy (2) 2
liver neoplasms - drug therapy (2) 2
liver resection (2) 2
liver transplantation (2) 2
mass (2) 2
medical research (2) 2
medicine, experimental (2) 2
menopause (2) 2
metals (2) 2
metastases (2) 2
musculoskeletal system (2) 2
myocardial infarction - therapy (2) 2
obesity (2) 2
oncology (2) 2
paclitaxel (2) 2
paclitaxel-eluting stent (2) 2
prognostic model (2) 2
proportional hazards models (2) 2
quality of life (2) 2
randomized controlled-trial (2) 2
registries (2) 2
regression analysis (2) 2
research (2) 2
sirolimus-eluting stent (2) 2
skeletal muscle (2) 2
skeletal muscle density (2) 2
skeletal muscle mass (2) 2
stents (2) 2
surgical outcomes (2) 2
surgical resection (2) 2
target vessel revascularization (2) 2
tertiary care centers (2) 2
thrombosis (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature Medicine, ISSN 1078-8956, 12/2017, Volume 23, Issue 12, pp. 1424 - 1435
textabstractHuman liver cancer research currently lacks in vitro models that can faithfully recapitulate the pathophysiology of the original tumor. We recently... 
MEDICINE, RESEARCH & EXPERIMENTAL | CHOLANGIOCARCINOMA | STEM-CELLS | BIOCHEMISTRY & MOLECULAR BIOLOGY | MOUSE | ESTABLISHMENT | GENOME | CELL BIOLOGY | HEPATOCELLULAR-CARCINOMA | IN-VITRO EXPANSION | ADULT LIVER | EXPRESSION | INACTIVATING MUTATIONS | Cell Proliferation | Primary Cell Culture - methods | Humans | Gene Expression Regulation, Neoplastic | Transcriptome | Male | Antineoplastic Agents - therapeutic use | Carcinoma, Hepatocellular - drug therapy | Antineoplastic Agents - isolation & purification | Carcinoma, Hepatocellular - genetics | Liver Neoplasms - pathology | Bile Duct Neoplasms - genetics | Tumor Cells, Cultured | Bile Duct Neoplasms - drug therapy | Precision Medicine | Drug Screening Assays, Antitumor - methods | Organoids - pathology | Liver Neoplasms - genetics | Liver Neoplasms - drug therapy | Mice, SCID | Xenograft Model Antitumor Assays | Cholangiocarcinoma - pathology | Animals | Cholangiocarcinoma - drug therapy | Carcinoma, Hepatocellular - pathology | Cholangiocarcinoma - genetics | Mice, Inbred NOD | Mice | Bile Duct Neoplasms - pathology | Cell culture | Liver cancer | Development and progression | Usage | Models | Research | Propagation | Liver | Extracellular signal-regulated kinase | Cultures | Hepatocellular carcinoma | Pharmacology | Gene expression | Tissues | Drug screening | Chemical compounds | Metastases | Screening | Utilities | Biomedical materials | Hepatocytes | Organoids | Xenografts | Biomarkers | In vivo methods and tests | Cholangiocarcinoma | Tumors | Cancer
Journal Article
Journal Article
World Journal of Surgery, ISSN 0364-2313, 05/2018, Volume 42, Issue 5, pp. 1506 - 1513
Background: When a liver lesion diagnosed as focal nodular hyperplasia (FNH) increases in size, it may cause doubt about the initial diagnosis. In many cases,... 
Surgery | Medicine & Public Health | Cardiac Surgery | Abdominal Surgery | Vascular Surgery | Thoracic Surgery | General Surgery | SURGERY | WOMEN | DIFFERENTIAL-DIAGNOSIS | MANAGEMENT | HEPATOCELLULAR ADENOMA | ACID-ENHANCED MRI | BENIGN LIVER-TUMORS | LESIONS | Growth | Health aspects | Liver | Hyperplasia | Biopsy | Imaging | Malignancy | Diagnosis | Adenoma | Patients | Original Scientific Report
Journal Article
Gastroenterology, ISSN 0016-5085, 10/2017, Volume 153, Issue 4, pp. 1107 - 1119.e10
Ligand binding to inhibitory receptors on immune cells, such as programmed cell death 1 (PD-1) and cytotoxic T-lymphocyte associated protein 4 (CTLA4),... 
GPC3 | MAGEC2 | Immunotherapy | Galectin 9 | SAFETY | CANCER | RESPONSES | ADVANCED MELANOMA | PEPTIDE-MHC | NIVOLUMAB | GASTROENTEROLOGY & HEPATOLOGY | UP-REGULATION | PD-1 | TETRAMERS | EXHAUSTION | Tumor Escape - drug effects | Antigens, CD - immunology | Up-Regulation | Immunotherapy - methods | Coculture Techniques | Humans | Hepatitis A Virus Cellular Receptor 2 - metabolism | Tumor Microenvironment | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Antigens, CD - metabolism | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Hepatitis A Virus Cellular Receptor 2 - antagonists & inhibitors | Carcinoma, Hepatocellular - drug therapy | T-Lymphocytes - metabolism | T-Lymphocytes - drug effects | Liver Neoplasms - pathology | Lymphocytes, Tumor-Infiltrating - metabolism | Antineoplastic Agents - pharmacology | Carcinoma, Hepatocellular - immunology | Hepatitis A Virus Cellular Receptor 2 - immunology | Cytokines - metabolism | Antibodies, Monoclonal - pharmacology | Cells, Cultured | Liver Neoplasms - drug therapy | CTLA-4 Antigen - metabolism | Programmed Cell Death 1 Receptor - metabolism | Antibodies, Neutralizing - pharmacology | Liver Neoplasms - immunology | Lymphocytes, Tumor-Infiltrating - drug effects | CTLA-4 Antigen - immunology | Signal Transduction - drug effects | Lymphocyte Activation - drug effects | Carcinoma, Hepatocellular - pathology | Liver Neoplasms - metabolism | T-Lymphocytes - immunology | Cell Proliferation - drug effects | Programmed Cell Death 1 Receptor - immunology | CTLA-4 Antigen - antagonists & inhibitors | Carcinoma, Hepatocellular - metabolism | Lymphocytes, Tumor-Infiltrating - immunology | Viral antibodies | Cell death | Analysis | Melanoma | Antibodies | T cells | Lung cancer, Non-small cell | Cancer | Liver cancer | Dendritic cells | Tumor antigens | Lung cancer | Immunity
Journal Article
Journal of Gastrointestinal Surgery, ISSN 1091-255X, 2019
The aim was to compare the prognostic accuracy of cross-sectional imaging of the 7th and 8th editions of the American Joint Committee on Cancer(AJCC) staging... 
Prognostic model | Perihilar cholangiocarcinoma | TNM stage | Klatskin
Journal Article
ISSN 1078-8956, 2017
Human liver cancer research currently lacks in vitro models that can faithfully recapitulate the pathophysiology of the original tumor. We recently described a... 
cancer models | self-renewal | disease model
Journal Article
World Journal of Surgery, ISSN 0364-2313, 11/2017, pp. 1 - 8
textabstractBackground: When a liver lesion diagnosed as focal nodular hyperplasia (FNH) increases in size, it may cause doubt about the initial diagnosis. In... 
Journal Article
JACC: Cardiovascular Interventions, ISSN 1936-8798, 10/2010, Volume 3, Issue 10, pp. 1051 - 1058
textabstractObjectives The aim of this study was to assess the 6-year clinical outcome after unrestricted use of sirolimus-eluting stents (SES) or... 
restenosis | major clinical study | heart infarction | sirolimus-eluting stent(s) | follow up | percutaneous coronary intervention | stent thrombosis | drug use | target vessel revascularization | outcome assessment | priority journal | female | human | clinical trial | paclitaxel | bare-metal stent(s) | revascularization | in-stent restenosis | treatment outcome | article | cardiology | drug eluting stent | implantation | controlled study | paclitaxel-eluting stent(s) | mortality | bare metal stent | adult | male | intermethod comparison | rapamycin | register | INTRAVASCULAR ULTRASOUND ANALYSIS | CARDIAC & CARDIOVASCULAR SYSTEMS | RISK-FACTORS | THROMBOSIS | TRIAL | SUBACUTE STENT | REAL-WORLD | IMPLANTATION | LARGE 2-INSTITUTIONAL COHORT | POOLED ANALYSIS | CORONARY-ARTERY-DISEASE | Angioplasty, Balloon, Coronary - instrumentation | Humans | Metals | Middle Aged | Male | Prosthesis Design | Angioplasty, Balloon, Coronary - adverse effects | Netherlands | Angioplasty, Balloon, Coronary - mortality | Time Factors | Female | Registries | Paclitaxel - administration & dosage | Myocardial Infarction - etiology | Stents | Cardiovascular Agents - administration & dosage | Drug-Eluting Stents | Risk Assessment | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Treatment Outcome | Coronary Artery Disease - mortality | Chi-Square Distribution | Sirolimus - administration & dosage | Coronary Artery Disease - therapy | Thrombosis - etiology | Aged
Journal Article
Journal of Hepatology, ISSN 0168-8278, 12/2016, Volume 65, Issue 6, p. 1163
Background & Aims: Hepatocellular adenoma (HCA) is a rare benign liver tumor, which typically develops in women in their reproductive phase and is associated... 
Reproductive health | Women | Liver diseases | Menopause | Benign | Adenoma | Quality of life | Liver cancer | Contraceptives | Magnetic resonance imaging | Computed tomography | Contraceptives (oral) | Ultrasound
Journal Article
Digestive Surgery, ISSN 0253-4886, 02/2018
textabstractBackground: Low skeletal muscle mass is associated with increased postoperative morbidity and worse survival following resection for perihilar... 
Sarcopenia | Prognosis | Computed tomography | Skeletal muscle mass | Perihilar cholangiocarcinoma | Skeletal muscle density
Journal Article